Doximity analyst ratings
Doximity analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
05/19/2022 | 45.07% | Piper Sandler | $81 → $44 | Maintains | Overweight |
05/18/2022 | 71.45% | Guggenheim | $70 → $52 | Maintains | Buy |
05/18/2022 | 51.67% | Jefferies | $78 → $46 | Maintains | Buy |
05/18/2022 | 31.88% | Raymond James | $60 → $40 | Maintains | Outperform |
05/18/2022 | 15.4% | Morgan Stanley | $55 → $35 | Maintains | Equal-Weight |
05/18/2022 | 48.37% | Baird | $68 → $45 | Maintains | Outperform |
05/18/2022 | 48.37% | Needham | $70 → $45 | Maintains | Buy |
05/18/2022 | 120.9% | SVB Leerink | $72 → $67 | Maintains | Outperform |
04/07/2022 | 130.79% | Guggenheim | → $70 | Initiates Coverage On | → Buy |
04/04/2022 | 81.34% | B of A Securities | → $55 | Initiates Coverage On | → Neutral |
03/23/2022 | 81.34% | Morgan Stanley | $62 → $55 | Maintains | Equal-Weight |
02/11/2022 | 143.98% | Goldman Sachs | → $74 | Initiates Coverage On | → Buy |
02/09/2022 | 97.82% | Raymond James | $80 → $60 | Maintains | Outperform |
02/09/2022 | 130.79% | Needham | $90 → $70 | Maintains | Buy |
12/17/2021 | 91.23% | Morgan Stanley | $72 → $58 | Maintains | Equal-Weight |
12/14/2021 | 97.82% | JP Morgan | $70 → $60 | Downgrades | Neutral → Underweight |
12/02/2021 | 157.17% | Jefferies | → $78 | Initiates Coverage On | → Buy |
11/17/2021 | 176.95% | Baird | → $84 | Initiates Coverage On | → Outperform |
11/10/2021 | 163.77% | Raymond James | $62 → $80 | Maintains | Outperform |
11/10/2021 | 196.74% | Needham | $62 → $90 | Maintains | Buy |
11/10/2021 | 137.39% | SVB Leerink | $65 → $72 | Maintains | Outperform |
08/31/2021 | 134.09% | Morgan Stanley | $52 → $71 | Maintains | Equal-Weight |
08/26/2021 | 130.79% | JP Morgan | → $70 | Downgrades | Overweight → Neutral |
08/11/2021 | 104.42% | Raymond James | $60 → $62 | Maintains | Outperform |
07/19/2021 | 71.45% | Morgan Stanley | → $52 | Initiates Coverage On | → Equal-Weight |
07/19/2021 | 97.82% | Raymond James | → $60 | Initiates Coverage On | → Outperform |
07/19/2021 | 104.42% | Needham | → $62 | Initiates Coverage On | → Buy |
07/19/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
07/19/2021 | 111.01% | Canaccord Genuity | → $64 | Initiates Coverage On | → Buy |
07/19/2021 | 114.31% | SVB Leerink | → $65 | Initiates Coverage On | → Outperform |
07/19/2021 | 124.2% | Piper Sandler | → $68 | Initiates Coverage On | → Overweight |
07/19/2021 | 18.69% | Goldman Sachs | → $36 | Initiates Coverage On | → Neutral |
07/19/2021 | 97.82% | JP Morgan | → $60 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
05/19/2022 | 45.07% | 派珀·桑德勒 | $81 → $44 | 維護 | 超重 |
05/18/2022 | 71.45% | 古根海姆 | $70 → $52 | 維護 | 買 |
05/18/2022 | 51.67% | 傑富瑞 | $78 → $46 | 維護 | 買 |
05/18/2022 | 31.88% | 雷蒙德·詹姆斯 | $60 → $40 | 維護 | 跑贏大盤 |
05/18/2022 | 15.4% | 摩根士丹利 | $55 → $35 | 維護 | 等重 |
05/18/2022 | 48.37% | 貝爾德 | $68 → $45 | 維護 | 跑贏大盤 |
05/18/2022 | 48.37% | 李約瑟 | $70 → $45 | 維護 | 買 |
05/18/2022 | 120.9% | SVB Leerink | $72 → $67 | 維護 | 跑贏大盤 |
04/07/2022 | 130.79% | 古根海姆 | → $70 | 開始承保 | →購買 |
04/04/2022 | 81.34% | B of A證券 | → $55 | 開始承保 | →中性 |
03/23/2022 | 81.34% | 摩根士丹利 | $62 → $55 | 維護 | 等重 |
02/11/2022 | 143.98% | 高盛 | → $74 | 開始承保 | →購買 |
02/09/2022 | 97.82% | 雷蒙德·詹姆斯 | $80 → $60 | 維護 | 跑贏大盤 |
02/09/2022 | 130.79% | 李約瑟 | $90 → $70 | 維護 | 買 |
12/17/2021 | 91.23% | 摩根士丹利 | $72 → $58 | 維護 | 等重 |
12/14/2021 | 97.82% | 摩根大通 | $70 → $60 | 評級下調 | 中性→減持 |
12/02/2021 | 157.17% | 傑富瑞 | → $78 | 開始承保 | →購買 |
11/17/2021 | 176.95% | 貝爾德 | → $84 | 開始承保 | →跑贏大盤 |
11/10/2021 | 163.77% | 雷蒙德·詹姆斯 | $62 → $80 | 維護 | 跑贏大盤 |
11/10/2021 | 196.74% | 李約瑟 | $62 → $90 | 維護 | 買 |
11/10/2021 | 137.39% | SVB Leerink | $65 → $72 | 維護 | 跑贏大盤 |
08/31/2021 | 134.09% | 摩根士丹利 | $52 → $71 | 維護 | 等重 |
08/26/2021 | 130.79% | 摩根大通 | → $70 | 評級下調 | 超重→中性 |
08/11/2021 | 104.42% | 雷蒙德·詹姆斯 | $60 → $62 | 維護 | 跑贏大盤 |
07/19/2021 | 71.45% | 摩根士丹利 | → $52 | 開始承保 | →等重 |
07/19/2021 | 97.82% | 雷蒙德·詹姆斯 | → $60 | 開始承保 | →跑贏大盤 |
07/19/2021 | 104.42% | 李約瑟 | → $62 | 開始承保 | →購買 |
07/19/2021 | — | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
07/19/2021 | 111.01% | 卡納科特·格納奇 | → $64 | 開始承保 | →購買 |
07/19/2021 | 114.31% | SVB Leerink | → $65 | 開始承保 | →跑贏大盤 |
07/19/2021 | 124.2% | 派珀·桑德勒 | → $68 | 開始承保 | →超重 |
07/19/2021 | 18.69% | 高盛 | → $36 | 開始承保 | →中性 |
07/19/2021 | 97.82% | 摩根大通 | → $60 | 開始承保 | →超重 |
Doximity Questions & Answers
多氧性問題與解答
The latest price target for Doximity (NYSE: DOCS) was reported by Guggenheim on May 18, 2022. The analyst firm set a price target for $52.00 expecting DOCS to rise to within 12 months (a possible 71.45% upside). 32 analyst firms have reported ratings in the last year.
古根海姆於2022年5月18日報道了Doximity(紐約證券交易所代碼:DOCS)的最新目標價。這家分析公司將目標價定為52.00美元,預計DOCS將在12個月內上漲至71.45%。去年有32家分析公司公佈了評級。
The latest analyst rating for Doximity (NYSE: DOCS) was provided by Guggenheim, and Doximity maintained their buy rating.
古根海姆對Doximity(紐約證券交易所代碼:DOCS)的最新分析師評級為買入,Doximity維持買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on May 18, 2022 so you should expect the next rating to be made available sometime around May 18, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公共財務報表,與Doximity的高管和客户交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Doximity的上一次評級是在2022年5月18日提交的,所以你應該預計下一次評級將在2023年5月18日左右的某個時候公佈。
While ratings are subjective and will change, the latest Doximity (DOCS) rating was a maintained with a price target of $70.00 to $52.00. The current price Doximity (DOCS) is trading at is $30.33, which is out of the analyst's predicted range.
雖然評級是主觀的,會發生變化,但最新的Doximity(DOCS)評級保持不變,目標價在70.00美元到52.00美元之間。Doximity(DOCS)目前的交易價格為30.33美元,超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。